| Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells GJ Melen, L Franco-Luzón, D Ruano, Á González-Murillo, A Alfranca, ... Cancer letters 371 (2), 161-170, 2016 | 70 | 2016 |
| Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology M Ramírez, J Garcia-Castro, GJ Melen, A Gonzalez-Murillo, ... Oncolytic virotherapy, 149-155, 2015 | 40 | 2015 |
| Benefits of exercise and immunotherapy in a murine model of human non-small-cell lung carcinoma. A Martín-Ruiz, C Fiuza-Luces, C Rincón-Castanedo, ... Exercise Immunology Review 26, 2020 | 39 | 2020 |
| Systemic oncolytic adenovirus delivered in mesenchymal carrier cells modulate tumor infiltrating immune cells and tumor microenvironment in mice with neuroblastoma L Franco-Luzón, Á González-Murillo, C Alcántara-Sánchez, ... Oncotarget 11 (4), 347, 2020 | 34 | 2020 |
| Genetic and immune changes associated with disease progression under the pressure of oncolytic therapy in A neuroblastoma outlier patient L Franco-Luzón, S García-Mulero, R Sanz-Pamplona, G Melen, D Ruano, ... Cancers 12 (5), 1104, 2020 | 15 | 2020 |
| MAVS (-/-) mesenchymal stem cells as oncolytic adenovirus ICOVIR-5 carriers for cancer treatment P Garcia-Rodriguez, A Morales-Molina, L Franco-Luzon, ... HUMAN GENE THERAPY 32 (19-20), A17-A17, 2021 | | 2021 |
| Estudio de efectos inmunes sobre el tumor, de mecanismos de resistencia y de las características biológicas de la terapia Celyvir L Franco Luzón | | 2020 |
| Characteristics of carrier cells associated with clinical response in children treated with adenoviral virotherapy administered in autologous marrow-derived mesenchymal cells. M Ramirez, L Franco-Luzón, Á González-Murillo, G Melen, D Ruano, ... Journal of Clinical Oncology 38 (15_suppl), e15217-e15217, 2020 | | 2020 |
| Peripheral blood tumor-infiltrating lymphocytes in a neuroblastoma model. ML Espinoza Vega, AL Luis Huertas, A González Murillo, L Franco-Luzón, ... | | 2020 |
| Peripheral blood tumor-infiltrating lymphocytes in a neuroblastoma model MLE Vega, ALL Huertas, AG Murillo, L Franco-Luzón, MR Orellana Cir Pediatr 33, 84-90, 2020 | | 2020 |
| Linfocitos infiltrantes de tumor en sangre periférica en un modelo de neuroblastoma MLE Vega, ALL Huertas, AG Murillo, L Franco-Luzón, MR Orellana Cir Pediatr 33, 84-90, 2020 | | 2020 |
| Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology. M Ramírez Orellana, J García-Castro, GJ Melen, Á González-Murillo, ... | | 2015 |
| Supplementary Materials: Genetic and Immune Changes Associated with Disease Progression under the Pressure of Oncolytic Therapy in A Neuroblastoma Outlier Patient L Franco-Luzón, S García-Mulero, R Sanz-Pamplona, G Melen, D Ruano, ... | | |
